Certain RNA molecules in the nerve cells in the brain last a life time without being renewed. Neuroscientists from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have now demonstrated that this is the case together ...
Apr 8, 2024
0
0
Research by Victor Ambros, Ph.D., provides new insights into a recently identified class of neurodevelopmental disorders called Argonaute syndromes. Dr. Ambros and colleagues believe their Proceedings of the National Academy ...
Mar 25, 2024
0
13
Researchers are passionate about their fields of study for a variety of reasons. For Satish Madala, his focus on asthma is deeply personal.
Jan 29, 2024
0
0
Scientists from Scripps Research have developed a small molecule that blocks the activity of a protein linked to autoimmune diseases, including systemic lupus erythematosus (SLE) and Crohn's disease. This protein, known as ...
Jan 11, 2024
0
46
In-vitro-fertilization (IVF), a fertility treatment that involves fertilizing eggs in the laboratory and later implanting them in the uterus, has been a source of hope for many people struggling to conceive. However, the ...
Jan 10, 2024
0
21
A pair of studies from the laboratory of Evangelos Kiskinis, Ph.D., associate professor in the Ken and Ruth Davee Department of Neurology's Division of Neuromuscular Disease and of Neuroscience, have uncovered novel cellular ...
Nov 14, 2023
0
37
Huntington's disease causes involuntary movements and dementia, has no cure, and is fatal. For the first time, UC Riverside scientists have shown they can slow its progression in flies and worms, opening the door to human ...
Nov 8, 2023
0
35
Researchers from IBB-UAB have developed a second-generation molecule that significantly improves the stabilization and inhibition of the aggregation of proteins involved in Transthyretin Amyloidosis (ATTR), a group of minority ...
Oct 18, 2023
0
0
In a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology, a team of researchers from City of Hope, one of the largest cancer research and treatment organizations in the United ...
Oct 14, 2023
0
64
An experimental drug targeting a genetic variant linked to Parkinson's disease had no effect on patients, according to the results of a new clinical trial published in The Lancet Neurology.
Aug 28, 2023
0
42
